grey box.jpg

One goal. Prevent cancer.

At the RUNX1 Research Program (RRP), our mission is to support patients with RUNX1 Familial Platelet Disorder by promoting awareness and funding world-class, collaborative research with an empowered patient community. 

img_about 2.jpg

We at the RRP are committed to finding a pre-leukemic cure for the inherited blood disorder RUNX1-FPD.  

We promote awareness, connect stakeholders, fund and support targeted and innovative research, and advocate for patients in the RUNX1 community.

RRP Team Photo 2019 including Eve.jpg

The RRP Team

Monica and Tim Babich co-founded RRP in late 2015 and serve as Co-Directors. Katrin Ericson serves as Executive Director, Amanda Eggen is our Patient Engagement and Clinical Program Manager, and Eve Ling is our Executive Assistant.

Learn more →


Executive Director

Dr. Ericson brings to the RRP a diverse set of experiences that span multiple sectors of the scientific and medical landscape. Most recently, she was at Amgen working in the Medical Affairs department for close to 8 years.

Read more →